MTOR and ovarian carcinoma: It furthermore impaired SKOV-3 cells’ migratory capacity and affected mTOR (mechanistic target of rapamycin) signalling (via down-regulation of Rictor and Raptor, constituents of mTORC1/mTORC2 complexes), associated with ovarian cancer progression [73].